Page last updated: 2024-12-07

tiglic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tiglic acid : A 2-methylbut-2-enoic acid having its double bond in trans-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-methylbut-2-enoic acid : A branched-chain fatty acid consisting of 2-butenoic acid having a methyl group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID125468
CHEMBL ID52416
CHEBI ID9592
CHEBI ID36432
SCHEMBL ID15042
MeSH IDM0054236

Synonyms (122)

Synonym
2-methylbut-2-enoic acid
trans-alpha,beta-dimethylacrylic acid
alpha-methylcrotonic acid
2-methylcrotonic acid
2,3-dimethylacrylic acid
CHEBI:9592 ,
methylmethacrylic acid
13201-46-2
(e)-2-methylbut-2-enoic acid
methyl methacrylic acid
CHEBI:36432
tiglinsaeure
LS-13047
2-butenoic acid, 2-methyl-, (e)-
crotonic acid, 2-methyl-, (e)-
nsc-44235
NSC44235 ,
einecs 201-295-0
(e)-2-methyl-2-butenoic acid
brn 1236500
2,3-dimethylacrylic acid, (e)-
alpha-methylcrotonic acid, (e)-
fema no. 3599
2-methyl-2-butenoic acid, (e)-
ai3-36118
nsc 44235
nsc-8999
cevadic acid
tiglinic acid
nsc8999 ,
trans-2-methyl-2-butenoic acid
trans-2-methylcrotonic acid
trans-2,3-dimethylacrylic acid
(e)-2-methylcrotonic acid
trans-.alpha.,.beta.-dimethylacrylic acid
(2e)-2-methylbut-2-enoic acid
2-butenoic acid, 2-methyl-, (2e)-
C08279
tiglic acid
(e)-2,3-dimethylacrylic acid
80-59-1
trans-2,3-dimethylacrylic acid, 98%
trans-2-methyl-2-butenoic acid, >=99%, fg
(e)-2-methyl-crotonic acid
alpha,beta-dimethyl acrylic acid
LMFA01020030
2-methyl-2e-butenoic acid
2-methyl-2-butenoic acid
tiglate
CHEMBL52416
AKOS003375681
BMSE000727
alpha,beta-dimethyl acrylic acid; 2-methyl-2-butenoic acid; (e)-2-methyl-crotonic acid
(2e)-2-methyl-2-butenoic acid
T0246
A839954
unii-i5792n03hc
i5792n03hc ,
hsdb 7614
4-02-00-01552 (beilstein handbook reference)
2-butenoic acid,2-methyl-
einecs 236-167-3
S3789
sabadillic acid
gtpl6499
SCHEMBL15042
tiglic acid [mi]
e)-2-methylcrotonic acid
(e)-.alpha.-methylcrotonic acid
methyl-2-butenoic acid, trans-2-
tiglic acid [hsdb]
2-methylbut-2-enoic acid, (e)-
trans-2-methyl-2-butenoic acid [fhfi]
trans-crotonic acid, 2-methyl-
2-methyl-(e)-2-butenoic acid
tiglic acid, (e)-
(2e)-2-methyl-2-butenoic acid #
methyl crotonic acid
alpha-methyl-crotonic acid
tiglicacid
mfcd00066864
2-methyl-2-butenoate
2-methyl-crotonic acid
(e)-2-methyl-crotonate
(2e)-2-methyl-2-butenoate
trans-2-methyl-2-butenoate
trans-2-methylcrotonic acid = trans-2-methyl-2-butenoic acid = tiglinic acid
tiglinate
2-methylbut-2-enoate
(e)-2-methylcrotonate
(e)-2,3-dimethylacrylate
cevadate
trans-2-methylcrotonic acid = trans-2-methyl-2-butenoic acid
trans-2,3-dimethylacrylate
e-tiglic acid
trans-2-methylcrotonic acid = trans-2-methyl-2-butenoate
trans-alpha,beta-dimethylacrylate
2,3-dimethylacrylate
methylbutenoicacid
2-methyl-(e)-2-butenoate
epsilon-tiglic acid
2-methyl-crotonate
(e)-2-methyl-2-butenoate
epsilon-tiglate
trans-2-methylcrotonate
D78012
F0001-2086
BCP18945
Q425475
Q27116830
e-tiglate
trans-2-methylcrotonic acid = trans-2-methyl-2-butenoic acid = tiglinate
HY-W012999
CS-W013715
CCG-266028
trans-2-methyl-but-2-enoic acid
2-methylbut-2-enoicacid
DTXSID80883257
CS-0356606
EN300-83150
EN300-370249
Z1205493556

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Relative liver weights of high-dose octan-3-ol males, and males and females dosed with oct-3-yl 2-methylcrotonate were significantly greater than those of the control."( Subchronic oral toxicity study on the three flavouring substances: octan-3-ol, 2-methylcrotonic acid and oct-3-yl 2-methylcrotonate in Wistar rats.
Andersen, R; Gry, J; Lindecrona, RH; Mølck, AM; Poulsen, M; Thorup, I, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
2-methylbut-2-enoic acidA branched-chain fatty acid consisting of 2-butenoic acid having a methyl group at position 2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID174708Gastric cytoprotective activity in male wistar rat1997Journal of medicinal chemistry, Jun-06, Volume: 40, Issue:12
Structure-cytoprotective activity relationship of simple molecules containing an alpha,beta-unsaturated carbonyl system.
AID1345904Human FFA2 receptor (Free fatty acid receptors)2011The Journal of biological chemistry, Mar-25, Volume: 286, Issue:12
Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (12.00)18.7374
1990's2 (8.00)18.2507
2000's10 (40.00)29.6817
2010's8 (32.00)24.3611
2020's2 (8.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.40 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index49.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]